The dates for the SIOPEN AGM and Neuroblastoma Research Symposium were announced. This meeting will be hosted by the German Society for Paediatric Oncology and Haematology and will take place @ Langenbeck Virchow Haus, Berlin, Germany on October 25-27, 2017.
Mission
To increase the understanding of neuroblastoma pathogenesis,
progression and treatment failure and to improve survival
and quality of life for children with neuroblastoma.
Main Objectives
- To consolidate a platform for global collaboration
- To establish networks of multidisciplinary caregivers
- To develop new trial protocols
- To develop standards for radiotherapy and surgery
- To develop SOPs for biomaterial collection, handling and storage
- To develop SOPs for application of major research technologies
- To identify leaders for specific topics
Scientific Topics/Plenary Sessions
- Molecular Risk Stratification
- Liquid Biopsies
- Tumor Heterogeneity+Tumor Microenvironment
- New Preclinical Models: PDX, GEMM, zebrafish
- New Immunotherapy Approaches
- New Drug Targets/Early Clinical Trials
- Neuroblastoma Pathogenesis/Genetics
- Targeting MYC
- Targeting ALK
- Targeting RAS/MAPK
- SIOPEN HR-NBL2 Clinical Trial Strategy
- Update ongoing SIOPEN trials: HR-NBL-1, LINES, VERITAS, OMS
- Update SIOPEN Bioportal
- Concept Biology+Relapse Umbrella Trial
